CPIX icon

Cumberland Pharmaceuticals
CPIX

Overview Fund Activity

28 hedge funds and large institutions have $26.6M invested in Cumberland Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 10 reducing their positions, and 4 closing their positions.

Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
2
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DGHMC
1
Dalton, Greiner, Hartman, Maher & Co
New York
$528K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$2.78M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.32M
4
PPA
4
Parametric Portfolio Associates
Washington
$80K
5
FGAM
5
Financial Gravity Asset Management
Texas
$36K

Top Sellers

1
AI
1
Ariel Investments
Illinois
$5.68M
2
BA
2
Bard Associates
Illinois
$0
3
Deutsche Bank
3
Deutsche Bank
Germany
$27K
4
SCM
4
Stonepine Capital Management
Oregon
$5.1M
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$601K
Name Holding Trade Value Shares
Change 		Shares
Change %
Barclays
26
Barclays
United Kingdom
$1K +$1K +85 New
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$1K +$1K +178 New
BA
28
Bard Associates
Illinois
– -$488K -76,615 Closed
TRCT
29
Tower Research Capital (TRC)
New York
– -$17K -2,596 Closed
LTFS
30
Ladenburg Thalmann Financial Services
Florida
– -$1K -136 Closed
1
2